JP2001521902A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521902A5
JP2001521902A5 JP2000518676A JP2000518676A JP2001521902A5 JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5 JP 2000518676 A JP2000518676 A JP 2000518676A JP 2000518676 A JP2000518676 A JP 2000518676A JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
crosslinking agent
polymer
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000518676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001521902A (ja
JP4452402B2 (ja
Filing date
Publication date
Priority claimed from US08/964,956 external-priority patent/US5985938A/en
Application filed filed Critical
Publication of JP2001521902A publication Critical patent/JP2001521902A/ja
Publication of JP2001521902A5 publication Critical patent/JP2001521902A5/ja
Application granted granted Critical
Publication of JP4452402B2 publication Critical patent/JP4452402B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000518676A 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用 Expired - Lifetime JP4452402B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/964,956 1997-11-05
US08/964,956 US5985938A (en) 1997-11-05 1997-11-05 Method for reducing oxalate
PCT/US1998/022606 WO1999022744A1 (en) 1997-11-05 1998-10-26 Use of aliphatic polyamines for reducing oxalate

Publications (3)

Publication Number Publication Date
JP2001521902A JP2001521902A (ja) 2001-11-13
JP2001521902A5 true JP2001521902A5 (cg-RX-API-DMAC7.html) 2006-01-05
JP4452402B2 JP4452402B2 (ja) 2010-04-21

Family

ID=25509224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000518676A Expired - Lifetime JP4452402B2 (ja) 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用

Country Status (10)

Country Link
US (3) US5985938A (cg-RX-API-DMAC7.html)
EP (2) EP1645278A3 (cg-RX-API-DMAC7.html)
JP (1) JP4452402B2 (cg-RX-API-DMAC7.html)
AR (1) AR016001A1 (cg-RX-API-DMAC7.html)
AU (1) AU1364799A (cg-RX-API-DMAC7.html)
CA (1) CA2349620C (cg-RX-API-DMAC7.html)
DE (1) DE69833134T2 (cg-RX-API-DMAC7.html)
TW (1) TW585772B (cg-RX-API-DMAC7.html)
WO (1) WO1999022744A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA989671B (cg-RX-API-DMAC7.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) * 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
AU2002257145B2 (en) * 2001-04-18 2005-06-02 Genzyme Corporation Method for lowering serum glucose
WO2002085381A1 (en) * 2001-04-18 2002-10-31 Genzyme Corporation Method for treating gout and binding uric acid
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
DE60212819T2 (de) * 2001-04-18 2006-11-23 Genzyme Corp., Cambridge Salzformarme polyallylamine
CA2444028A1 (en) * 2001-04-18 2002-10-31 Genzyme Corporation Methods of treating syndrome x with aliphatic polyamines
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
EP1923064B1 (en) 2001-04-18 2017-06-28 Genzyme Corporation Use of amine polymer for lowering serum glucose
KR100956013B1 (ko) 2001-04-23 2010-05-06 샤이어 인터내쇼날 라이센싱 비.브이. 희토류 화합물을 포함하는 신장 결석 질환 치료용 약제학적 조성물
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
WO2003042380A2 (en) * 2001-10-05 2003-05-22 Ixion Biotechnology, Inc. Materials and methods for reducing oxalate concentrations in fluids
US6600011B2 (en) * 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
WO2003031501A1 (en) * 2001-10-09 2003-04-17 Genzyme Corporation Process for purification and drying of polymer hydrogels
WO2004037274A1 (en) * 2002-10-22 2004-05-06 Genzyme Corporation Amine polymers for promoting bone formation
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
ES2453048T3 (es) 2004-03-30 2014-04-03 Relypsa, Inc. Polímeros de unión de ión y usos de los mismos
WO2005110469A2 (en) * 2004-05-07 2005-11-24 Oxthera, Inc. Methods and compositions for reducing oxalate concentrations
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
EP1945196A2 (en) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
WO2007070052A2 (en) * 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
EP2016114A2 (en) * 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
EP2043627A2 (en) * 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
WO2008008872A2 (en) * 2006-07-14 2008-01-17 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
US20100124542A1 (en) * 2006-07-18 2010-05-20 Genzyme Corporation Amine dendrimers
WO2008105911A2 (en) 2006-08-02 2008-09-04 Altus Pharmaceuticals Inc. Crystallized oxalate decarboxylase and methods of use
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8802094B2 (en) * 2006-10-25 2014-08-12 Wisconsin Alumni Research Foundation Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody
BRPI0716320A2 (pt) * 2006-10-26 2014-02-25 Wisconsin Alumni Res Found Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
JP2010519298A (ja) * 2007-02-23 2010-06-03 ゲンズイメ コーポレーション アミンポリマー組成物
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
WO2008113364A2 (en) * 2007-03-20 2008-09-25 Recepticon Aps Amino derivatives to prevent nephrotoxicity and cancer
US20100166696A1 (en) * 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
EP2217215A1 (en) * 2007-12-14 2010-08-18 Genzyme Corporation Coated pharmaceutical compositions
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
JPWO2010123039A1 (ja) * 2009-04-21 2012-10-25 株式会社医学生物学研究所 生物学的材料の不動化を行うための組成物
US9714456B2 (en) 2013-01-18 2017-07-25 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
HK1220607A1 (zh) * 2013-03-15 2017-05-12 Genzyme Corporation 晚期糖化终产物(age)前体的螯合剂
WO2014197806A2 (en) 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
US10435528B2 (en) 2013-09-17 2019-10-08 Aquanano Llc High-capacity anion exchange materials
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
CN107960105B (zh) 2015-04-02 2025-05-16 武汉康复得生物科技股份有限公司 用于降解不溶性和可溶性草酸的高效草酸降解酶
GB201718803D0 (en) * 2017-11-14 2017-12-27 Phoenix Molecular Pte Ltd Method for isolation of nucleic acids
US11993670B2 (en) 2018-06-06 2024-05-28 The Board Of Trustees Of The University Of Illinois Zwitterionic biocompatible polymers, methods, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198396A (en) * 1974-07-03 1980-04-15 Warren-Teed Laboratories, Inc. Dissolution of gallstones
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS60202869A (ja) * 1984-03-26 1985-10-14 Ajinomoto Co Inc 大環状ポリアミン誘導体及びその用途
DE3727082A1 (de) * 1987-08-14 1989-02-23 Goedecke Ag Pharmazeutische zubereitungen zur behandlung der urolithiasis
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
NZ335329A (en) * 1996-10-23 2001-06-29 Dow Chemical Co Water soluble polyether glycol polymer capable of complexing phosphate or oxalate used for reduction of dietary phosphate or oxalate absorption
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate

Similar Documents

Publication Publication Date Title
JP2001521902A5 (cg-RX-API-DMAC7.html)
JP2001521890A5 (cg-RX-API-DMAC7.html)
WO1999033452A3 (en) Amine-containing copolymers as bile acid sequestrants
JP2004535384A5 (cg-RX-API-DMAC7.html)
JP2004528332A5 (cg-RX-API-DMAC7.html)
JP2004526778A5 (cg-RX-API-DMAC7.html)
JPH11152398A5 (cg-RX-API-DMAC7.html)
JP2021536523A5 (cg-RX-API-DMAC7.html)
CA2444046A1 (en) Use of colesevelam in reducing serum glucose
JP2002541278A5 (cg-RX-API-DMAC7.html)
EP1645278A3 (en) Use of aliphatic polyamines for reducing oxalate
KR960703607A (ko) 경구적 투여를 위한 포스페이트-결합 중합체(phosphate-vinding polymers for oral administration)
EP0827027A3 (en) Curable compositions
JP2004520473A5 (cg-RX-API-DMAC7.html)
KR950031088A (ko) 교차 결합된 음이온 교환 입자 및 그 제조 방법
JP2005517062A5 (cg-RX-API-DMAC7.html)
ATE273341T1 (de) Strikt alternierende poly(alkylenoxid)copolymere
CA1237229A (en) Method for making conductive member for skin contact electrode containing sulfonated polymer material
JP2001509529A5 (cg-RX-API-DMAC7.html)
JPH11295933A5 (cg-RX-API-DMAC7.html)
JP2013513135A5 (cg-RX-API-DMAC7.html)
RU96124822A (ru) Поперечно-сшитые полимеры для удаления из организма человека солей желчных кислот
ATE288956T1 (de) Verwendung eines amphoteren polymeres zur behandlung ausgewählter harter oberflächen
EP0473793A4 (en) Curable composition
JP2004244633A5 (cg-RX-API-DMAC7.html)